Epidemiology Study in Major Orthopaedic Surgery

This study has been completed.
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by:
Hoersholm Hospital
ClinicalTrials.gov Identifier:
NCT00159185
First received: September 9, 2005
Last updated: July 20, 2006
Last verified: September 2005
  Purpose

The purpose of this study is to:

  • Create a database including a description of the patient population that undergoes total hip replacement with special emphasis on orthopedic and cardiovascular complications and the quality of life 1 year postoperatively.
  • Characterise the patient at risk for the above mentioned events
  • Create methods for predicting patients at risk for short-term (90 days) and long term (1 year) complications in relation to hip replacement surgery.

Condition
Thrombosis
Postoperative Complications
Quality of Life

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Official Title: Epidemiology Study in Major Orthopaedic Surgery

Resource links provided by NLM:


Further study details as provided by Hoersholm Hospital:

Estimated Enrollment: 500
Study Start Date: January 2004
Estimated Study Completion Date: May 2006
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients operated with Hip Arthroplasty Replacement in Hillerød and Hørsholm Hospitals from 1.1 2004.

Exclusion Criteria:

  • Written informed consent denied
  • Patients under 18 years of age.
  • Patients not habitants of Denmark at the time of the operation.
  • Patients without a CPR-number (civil registration number).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00159185

Locations
Denmark
Hoersholm Hospital
Hoersholm, Denmark, 2970
Sponsors and Collaborators
Hoersholm Hospital
GlaxoSmithKline
Investigators
Study Chair: Camilla Ryge, MD Hoersholm Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00159185     History of Changes
Other Study ID Numbers: ESMOS
Study First Received: September 9, 2005
Last Updated: July 20, 2006
Health Authority: Denmark: The Regional Committee on Biomedical Research Ethics
Denmark: Danish Dataprotection Agency

Keywords provided by Hoersholm Hospital:
Arthroplasty, Replacement, Hip
Epidemiology

Additional relevant MeSH terms:
Postoperative Complications
Thrombosis
Cardiovascular Diseases
Embolism and Thrombosis
Pathologic Processes
Vascular Diseases

ClinicalTrials.gov processed this record on October 20, 2014